ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

QBIO Q BioMed Inc (CE)

0.000001
0.00 (0.00%)
May 16 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0.00
Bid Price
Ask Price
News -
Day High

Low
0.000001

52 Week Range

High
0.0155

Day Low
Company Name Stock Ticker Symbol Market Type
Q BioMed Inc (CE) QBIO OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.000001 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.000001
Trades Volume Avg Volume 52 Week Range
0 0.00 - 0.000001 - 0.0155
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.000001 USD

Q BioMed Inc (CE) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
0 145.09M 41.00M 284k -3.49M -0.02 0.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Q BioMed (CE) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No QBIO Message Board. Create One! See More Posts on QBIO Message Board See More Message Board Posts

Historical QBIO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.0000010.00020.0000010.0000017,4750.000.00%
1 Month0.0000010.00060.0000010.000423216,9900.000.00%
3 Months0.00010.00060.0000010.000193116,885-0.0001-99.00%
6 Months0.00110.00120.0000010.000441114,477-0.0011-99.91%
1 Year0.00920.01550.0000010.004692104,960-0.0092-99.99%
3 Years1.051.060.0000010.0443578576,873-1.05-100.00%
5 Years1.923.750.0000010.2249112374,896-1.92-100.00%

Q BioMed (CE) Description

Q BioMed Inc. ''Q`` is a biomedical acceleration and development company focused on acquiring companies and biomedical assets in clinical stage or and near revenue development. Q is dedicated to providing these target companies strategic resources, developmental support, and expansion capital to ensure they meet their developmental potential enabling them to provide products to patients in need.